Valuation : Terumo Corporation

Market Cap 3,432B 22.25B 19.13B 17.99B 16.43B 30.72B 2,104B 30.82B 213B 82.47B 1,077B 83.54B 81.72B P/E 2027 *
17.7x
P/E 2028 * 18.2x
Enterprise Value 3,478B 22.54B 19.39B 18.23B 16.65B 31.13B 2,132B 31.23B 216B 83.57B 1,092B 84.66B 82.81B EV / Sales 2027 *
2.76x
EV / Sales 2028 * 2.54x
Free-Float
97.07%
Yield 2027 *
1.56%
Yield 2028 * 1.71%
1 day-1.98%
1 week-8.57%
Current month-7.53%
1 month-9.67%
3 months+1.84%
6 months+13.93%
Current year+2.49%
1 week 2,314
Extreme 2314
2,540
1 month 2,314
Extreme 2314
2,689
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,689
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-1.98%-8.57%-12.46%+9.05% 22.7B
-0.42%-1.84%-18.51%+7.61% 187B
+1.15%+3.88%+1.37%+17.82% 120B
-1.86%+2.27%+13.15%+85.74% 63.15B
-3.40%-6.29%+12.38%+45.24% 52.36B
-1.54%-1.79%-3.98%-30.82% 50.32B
-2.02%-3.47%+9.18%-16.21% 33.17B
0.00%+4.45% - - 32.1B
-0.81%-0.33%+35.59%-15.82% 23.93B
-0.99%-3.46%-8.44%+0.06% 21.9B
Average -1.39%-1.04%+3.14%+11.41% 60.75B
Weighted average by Cap. -1.27%-0.88%-2.33%+15.81%

Financials

2027 *2028 *
Net sales 1,259B 8.16B 7.02B 6.6B 6.02B 11.27B 772B 11.3B 78.25B 30.25B 395B 30.64B 29.97B 1,339B 8.68B 7.46B 7.02B 6.41B 11.98B 821B 12.02B 83.23B 32.17B 420B 32.59B 31.88B
Net income 195B 1.26B 1.09B 1.02B 933M 1.74B 119B 1.75B 12.12B 4.68B 61.2B 4.75B 4.64B 192B 1.24B 1.07B 1.01B 918M 1.72B 118B 1.72B 11.93B 4.61B 60.23B 4.67B 4.57B
Net Debt 45.99B 298M 256M 241M 220M 412M 28.2B 413M 2.86B 1.11B 14.44B 1.12B 1.1B -26.39B -171M -147M -138M -126M -236M -16.18B -237M -1.64B -634M -8.29B -643M -628M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
08/09/26 ¥2,326.50 -1.98% 3,938,300
07/09/26 ¥2,373.50 -2.41% 4,321,600
04/09/26 ¥2,432.00 -1.44% 3,436,100
03/09/26 ¥2,467.50 -0.06% 3,345,100
02/09/26 ¥2,469.00 -2.97% 4,819,400
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,373.50JPY
Average target price
3,140.77JPY
Spread / Average Target
+32.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!